Glaxosmithkline Plc Profitability Analysis

GSK -  USA Stock  

USD 40.10  0.60  1.52%

For Glaxosmithkline Plc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Glaxosmithkline Plc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Glaxosmithkline Plc ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Glaxosmithkline Plc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Glaxosmithkline Plc ADR over time as well as its relative position and ranking within its peers. Please check Risk vs Return Analysis.

Search Current Profitability Trends 

 
Refresh
The current Price to Sales Ratio is estimated to increase to 2.27, while Return on Sales is projected to decrease to 0.21. The current Income Tax Expense is estimated to increase to about 813.4 M, while Consolidated Income is projected to decrease to under 5.9 B.

Glaxosmithkline Plc Revenues

34.39 BillionShare
The market value of Glaxosmithkline Plc ADR is measured differently than its book value, which is the value of Glaxosmithkline that is recorded on the company's balance sheet. Investors also form their own opinion of Glaxosmithkline Plc's value that differs from its market value or its book value, called intrinsic value, which is Glaxosmithkline Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaxosmithkline Plc's market value can be influenced by many factors that don't directly affect Glaxosmithkline Plc ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Glaxosmithkline Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine Glaxosmithkline Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaxosmithkline Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Glaxosmithkline Plc ADR Price to Sales vs. Price to Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Glaxosmithkline Plc's current stock value. Our valuation model uses many indicators to compare Glaxosmithkline Plc value to that of its competitors to determine the firm's financial worth.
Glaxosmithkline Plc ADR is rated # 2 in price to earning category among related companies. It is rated # 2 in price to sales category among related companies fabricating about  0.23  of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for Glaxosmithkline Plc ADR is roughly  4.43 . The current Price to Sales Ratio is estimated to increase to 2.27

Glaxosmithkline Price to Sales vs. Price to Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Glaxosmithkline Plc 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
13.59 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Glaxosmithkline Plc 
P/S 
 = 
MV Per Share 
Revenue Per Share 
3.07 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Glaxosmithkline Price to Sales Comparison

Glaxosmithkline Plc Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Glaxosmithkline Plc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Glaxosmithkline Plc will eventually generate negative long term returns. The profitability progress is the general direction of Glaxosmithkline Plc's change in net profit over the period of time. It can combine multiple indicators of Glaxosmithkline Plc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2021
Consolidated Income6.4 B5.9 B
Net Income5.7 B5.4 B
Net Income Common Stock5.7 B5.4 B
Net Income to Non Controlling Interests639 M509.2 M
Operating Income7.8 B7.6 B
Income Tax Expense580 M813.4 M
Net Income Per Employee61 K49.4 K
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc operates under Drug Manufacturers - General classification in the United States and is traded on New York Stock Exchange. It employs 94066 people.

Glaxosmithkline Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Glaxosmithkline Plc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Glaxosmithkline Plc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Glaxosmithkline Plc's important profitability drivers and their relationship over time.

Glaxosmithkline Plc Profitability Trends

Glaxosmithkline Plc profitability trend refers to the progression of profit or loss within a business. An upward trend means that Glaxosmithkline Plc's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Glaxosmithkline Plc's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Glaxosmithkline Plc Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Glaxosmithkline Plc different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Glaxosmithkline Plc in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Glaxosmithkline Plc's future profitability.

Use Glaxosmithkline Plc in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Glaxosmithkline Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glaxosmithkline Plc will appreciate offsetting losses from the drop in the long position's value.

Glaxosmithkline Plc Pair Trading

Glaxosmithkline Plc ADR Pair Trading Analysis

Correlation analysis and pair trading evaluation for Glaxosmithkline Plc and Horizon Therapeutics. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Glaxosmithkline Plc position

In addition to having Glaxosmithkline Plc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Value Thematic Idea Now

Large Value
Large Value Theme
Funds or Etfs that invest in the undervalued stocks of large-sized companies. Large Value theme has 40 constituents.
View All  Next Launch Large Value
Please check Risk vs Return Analysis. Note that the Glaxosmithkline Plc ADR information on this page should be used as a complementary analysis to other Glaxosmithkline Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Glaxosmithkline Stock analysis

When running Glaxosmithkline Plc ADR price analysis, check to measure Glaxosmithkline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaxosmithkline Plc is operating at the current time. Most of Glaxosmithkline Plc's value examination focuses on studying past and present price action to predict the probability of Glaxosmithkline Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Glaxosmithkline Plc's price. Additionally, you may evaluate how the addition of Glaxosmithkline Plc to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
To fully project Glaxosmithkline Plc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Glaxosmithkline Plc ADR at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Glaxosmithkline Plc's income statement, its balance sheet, and the statement of cash flows.
Potential Glaxosmithkline Plc investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Glaxosmithkline Plc investors may work on each financial statement separately, they are all related. The changes in Glaxosmithkline Plc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Glaxosmithkline Plc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.